Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,130 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05279521 | The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer. | unknown | N/A | 104 | National Taiwan University HospitalOTHER | 0 | Mar 15, 2022 | clinicaltrials |
| NCT04228237 | LUng CAncer focuS - Long-term Monitoring of Bronchogenic Carcinoma Patients (LUCAS)(LUCAS) | unknown | — | 2,300 | Ceska Lekarska Spolecnost Jana Evangelisty Purkyne z.s.OTHER | 1 |
| Mar 9, 2022 |
| clinicaltrials |
| NCT01951469 | Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer | unknown | Phase 3 | 160 | Sun Yat-sen UniversityOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT04690686 | Immunopheresis Alone or in Combination With Paclitaxel or Atezolizumab in Non-small Cell Lung Cancer (NSCLC). | unknown | Phase 2 | 24 | Immunicom IncINDUSTRY | 1 | Mar 8, 2022 | clinicaltrials |
| NCT05267392 | Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy(IDEAR) | unknown | Phase 1 / Phase 2 | 30 | Instituto Portugues de Oncologia, Francisco Gentil, PortoOTHER | 1 | Mar 4, 2022 | clinicaltrials |
| NCT04956146 | Fruquintinib Combined With Sintilimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer | unknown | Phase 2 | 46 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT02607592 | A Prospective Multi-center Phase III Randomized Controlled Trial(NACA) | unknown | Phase 3 | 293 | Sun Yat-sen UniversityOTHER | 1 | Feb 25, 2022 | clinicaltrials |
| NCT05254132 | Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging(SALMON) | unknown | — | 1,000 | OncoRadiomicsINDUSTRY | 0 | Feb 24, 2022 | clinicaltrials |
| NCT05252065 | Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer | unknown | — | 40 | Guizhou Medical UniversityOTHER | 0 | Feb 23, 2022 | clinicaltrials |
| NCT05252091 | An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC | unknown | Phase 2 | 30 | Henan Cancer HospitalOTHER_GOV | 0 | Feb 23, 2022 | clinicaltrials |
| NCT05245994 | An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese | unknown | Phase 2 | 60 | Li Zhang, MDOTHER | 1 | Feb 18, 2022 | clinicaltrials |
| NCT03221400 | PEN-866 in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 340 | Tarveda TherapeuticsINDUSTRY | 1 | Feb 17, 2022 | clinicaltrials |
| NCT05234138 | Generation Of a Lung Biobank for Future Use(GOLF) | unknown | — | 1,000 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 10, 2022 | clinicaltrials |
| NCT05230563 | A Clinical Study of LUNG-CT CAD Decision Support | unknown | N/A | 8 | TaiHao Medical Inc.INDUSTRY | 1 | Feb 9, 2022 | clinicaltrials |
| NCT03801200 | Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC | unknown | Phase 2 | 90 | Hubei Cancer HospitalOTHER | 1 | Feb 8, 2022 | clinicaltrials |
| NCT02446704 | Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy | unknown | Phase 1 / Phase 2 | 66 | Zofia PiotrowskaOTHER | 1 | Feb 7, 2022 | clinicaltrials |
| NCT05137912 | Neoadjuvant Immunotherapy in Advanced NSCLC | unknown | — | 10 | Power Life Sciences Inc.INDUSTRY | 1 | Feb 7, 2022 | clinicaltrials |
| NCT05202249 | Effect of Muscle and Skin Fixation of Thoracic Drainage Tube on Postoperative Pain | unknown | N/A | 60 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Feb 4, 2022 | clinicaltrials |
| NCT05223595 | A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC | unknown | Phase 1 | 42 | Changchun GeneScience Pharmaceutical Co., Ltd.INDUSTRY | 1 | Feb 4, 2022 | clinicaltrials |
| NCT05221814 | Pathological Classification of Pulmonary Nodules in Images Using Deep Learning | unknown | — | 2,000 | Jiangxi Provincial Cancer HospitalOTHER | 1 | Feb 3, 2022 | clinicaltrials |
| NCT05180851 | Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study(YSCH-01) | unknown | Early Phase 1 | 28 | Shanghai Fengxian District Central HospitalOTHER | 1 | Feb 1, 2022 | clinicaltrials |
| NCT05218759 | Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC | unknown | N/A | 30 | Shanghai Chest HospitalOTHER | 0 | Feb 1, 2022 | clinicaltrials |
| NCT05210946 | A Single-Arm Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients | unknown | N/A | 20 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jan 27, 2022 | clinicaltrials |
| NCT05207904 | Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases | unknown | Phase 2 | 41 | Sun Yat-sen UniversityOTHER | 1 | Jan 26, 2022 | clinicaltrials |
| NCT05209256 | Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC | unknown | Phase 2 / Phase 3 | 90 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 0 | Jan 26, 2022 | clinicaltrials |
| NCT05204628 | A Study to Evaluate and Compare the Efficacy and Safety of XZP-3621 Versus Crizotinib | unknown | Phase 3 | 238 | Xuanzhu Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 24, 2022 | clinicaltrials |
| NCT01024829 | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC(PET Boost) | unknown | N/A | 150 | The Netherlands Cancer InstituteOTHER | 5 | Jan 21, 2022 | clinicaltrials |
| NCT04595734 | Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors. | unknown | — | 500 | Western Sydney Local Health DistrictOTHER | 1 | Jan 21, 2022 | clinicaltrials |
| NCT05065398 | A Phase II Clinical Trial to Evaluate HLX208 in Advanced Non-small Cell Lung Cancer Patients With BRAF V600 Mutation | unknown | Phase 2 | 20 | Shanghai Henlius BiotechINDUSTRY | 1 | Jan 21, 2022 | clinicaltrials |
| NCT05165355 | Adjuvant Targeted-therapy for Patients With Resected High-risk EGFR-mutant Stage IB-IIA Non-small Cell Lung Carcinoma(ATHEM) | unknown | Phase 2 | 90 | Tongji UniversityOTHER | 1 | Jan 18, 2022 | clinicaltrials |
| NCT05191849 | Circulating EV Long RNA Profiles in SCLC | unknown | N/A | 60 | Fudan UniversityOTHER | 1 | Jan 14, 2022 | clinicaltrials |
| NCT05192681 | Tislelizumab as Cross-line Treatment for Advanced NSCLC | unknown | Phase 2 | 35 | Fujian Cancer HospitalOTHER_GOV | 1 | Jan 14, 2022 | clinicaltrials |
| NCT05158491 | Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC | unknown | Phase 1 / Phase 2 | 63 | JenKem Technology Co., Ltd.INDUSTRY | 1 | Jan 5, 2022 | clinicaltrials |
| NCT05176067 | Randomized Controlled Clinical Study of Drug Therapy Combined With Thoracic Radiotherapy for Non-oligometastatic NSCLC | unknown | N/A | 88 | Guizhou Medical UniversityOTHER | 0 | Jan 4, 2022 | clinicaltrials |
| NCT05177497 | SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC | unknown | Phase 2 | 19 | Shanghai Chest HospitalOTHER | 0 | Jan 4, 2022 | clinicaltrials |
| NCT04529915 | Multicenter Clinical Research for Early Diagnosis of Lung Cancer Using Blood Plasma Derived Exosome | unknown | — | 470 | Korea University Guro HospitalOTHER | 1 | Dec 30, 2021 | clinicaltrials |
| NCT04025424 | Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519)(ICIPRESIST19) | unknown | — | 350 | Russian Academy of Medical SciencesOTHER | 1 | Dec 28, 2021 | clinicaltrials |
| NCT05170581 | Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer | unknown | Phase 2 | 30 | The Second Affiliated Hospital of Shandong First Medical UniversityOTHER | 1 | Dec 28, 2021 | clinicaltrials |
| NCT05167604 | Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC | unknown | — | 150 | Tang-Du HospitalOTHER | 1 | Dec 22, 2021 | clinicaltrials |
| NCT05167851 | The Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer | unknown | Phase 2 | 68 | Yonsei UniversityOTHER | 1 | Dec 22, 2021 | clinicaltrials |
| NCT02743923 | Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer | unknown | Phase 3 | 203 | The Netherlands Cancer InstituteOTHER | 1 | Dec 21, 2021 | clinicaltrials |
| NCT05162235 | Augmented Reality-assisted Localization of Solitary Pulmonary Nodules for Precise Sublobar Lung Resection(ARPL) | unknown | N/A | 20 | Shanghai Chest HospitalOTHER | 0 | Dec 17, 2021 | clinicaltrials |
| NCT05157503 | Treatment of Patients With Stage III Non-small Cell Lung Cancer in Russia" | unknown | — | 1 | Autonomous Non-Profit Organization National Society of Onco-PulmonologistsOTHER | 1 | Dec 15, 2021 | clinicaltrials |
| NCT05157542 | Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC | unknown | Phase 1 | 9 | Juan LI, MDOTHER | 1 | Dec 15, 2021 | clinicaltrials |
| NCT04901754 | Camrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung Cancer(CAMERA) | unknown | Phase 2 | 38 | Henan Cancer HospitalOTHER_GOV | 1 | Dec 8, 2021 | clinicaltrials |
| NCT04989322 | Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC | unknown | Phase 2 | 46 | Dr Joanne CHIUOTHER | 1 | Dec 8, 2021 | clinicaltrials |
| NCT05072561 | Feasibility of Radioisotope-guided Excision of Mediastinal Lymph Nodes in Patients With Non-small Cells Lung Carcinoma(SLN_NSCLC) | unknown | N/A | 60 | Istituto Clinico HumanitasOTHER | 1 | Dec 8, 2021 | clinicaltrials |
| NCT05141786 | A Study of MRG002 in the Treatment of Patients With HER2-mutated Unresectable/Metastatic Non-small Cell Lung Cancer (NSCLC). | unknown | Phase 2 | 100 | Shanghai Miracogen Inc.INDUSTRY | 1 | Dec 2, 2021 | clinicaltrials |
| NCT02897479 | A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer | unknown | Phase 2 | 76 | Hutchison Medipharma LimitedINDUSTRY | 1 | Nov 30, 2021 | clinicaltrials |
| NCT05134558 | Xenon-enhanced Ventilation CT-guided Radiotherapy for Lung Cancer Treatment | unknown | N/A | 60 | National Taiwan University HospitalOTHER | 1 | Nov 26, 2021 | clinicaltrials |
Data updated 24 days agoSource updated Mar 15, 2022source: clinicaltrials